References
- Agalliu, I., Wang, Z., Wang, T., Dunn, A., Parikh, H., Myers, T., Burk, R. D., & Amundadottir, L. (2013). Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. PloS One, 8(4), e60083. https://doi.org/10.1371/journal.pone.0060083
- Badalato, L., Kalokairinou, L., & Borry, P. (2017). Third party interpretation of raw genetic data: An ethical exploration. European Journal of Human Genetics: EJHG, 25(11), 1189–1194. https://doi.org/10.1038/ejhg.2017.126
- Baptista, N. M., Christensen, K. D., Carere, D. A., Broadley, S. A., Roberts, J. S., & Green, R. C. (2016). Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genetics in Medicine, 18(9), 924–932. https://doi.org/10.1038/gim.2015.192
- Beauchamp, T. L., & Childress, J. F. (2019). Principles of biomedical ethics (8th ed.). Oxford University Press.
- Boesen, M. (2019, February 21). I got a double mastectomy after a genetic test. Then I learned the results were wrong. Huffington Post. https://www.huffpost.com/entry/brca-genetic-testing-mastectomy_n_5c6c39fbe4b012225acd80d3
- Casas, K. A. (2018). Adoptees’ pursuit of genomic testing to fill gaps in family health history and reduce healthcare disparity. Narrative Inquiry in Bioethics, 8(2), 131–135. https://doi.org/10.1353/nib.2018.0050
- Castéra, L., Harter, V., Muller, E., Krieger, S., Goardon, N., Ricou, A., Rousselin, A., Paimparay, G., Legros, A., Bruet, O., Quesnelle, C., Domin, F., San, C., Brault, B., Fouillet, R., Abadie, C., Béra, O., Berthet, P., Frébourg, T., & Vaur, D. (2018). Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. Genetics in Medicine, 20(12), 1677–1686. https://doi.org/10.1038/s41436-018-0005-9
- Downing, N. S., & Ross, J. S. (2014). Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe’s Personal Genome Service. JAMA, 311(8), 793–794. https://doi.org/10.1001/jama.2014.148
- Eng, C., & Sharp, R. R. (2010). Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: The problem of misattributed equivalence. Science Translational Medicine, 2(17), 17cm5. https://doi.org/10.1126/scitranslmed.3000214
- Finnis, J. (2011). Natural law and natural rights (2nd ed.). Oxford University Press.
- Foden-Vencil, K. (2018, March 26). Oregon cancer initiative warns of false reassurance over 23andMe genetic test. Oregon Public Broadcasting. https://www.opb.org/news/article/23andme-cancer-result-portland-legacy-institute-warning/
- Fullerton, S. M. (2016). No panacea: Next-gen sequencing will not mitigate adoptees’ lack of genetic family health history. The American Journal of Bioethics, 16(12), 41–43. https://doi.org/10.1080/15265161.2016.1240261
- Graffeo, R., Livraghi, L., Pagani, O., Goldhirsch, A., Partridge, A. H., & Garber, J. E. (2016). Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Research and Treatment, 160(3), 393–410. https://doi.org/10.1007/s10549-016-4003-9
- Griffin, J. (1987). Well-being: Its meaning, measurement and moral importance. Oxford University Press.
- Heald, B., Edelman, E., & Eng, C. (2012). Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. European Journal of Human Genetics, 20(5), 547–551. https://doi.org/10.1038/ejhg.2011.224
- Kast, K., Rhiem, K., Wappenschmidt, B., Hahnen, E., Hauke, J., Bluemcke, B., Zarghooni, V., Herold, N., Ditsch, N., Kiechle, M., Braun, M., Fischer, C., Dikow, N., Schott, S., Rahner, N., Niederacher, D., Fehm, T., Gehrig, A., Mueller-Reible, C., … Engel, C. (2016). Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. Journal of Medical Genetics, 53(7), 465–471. https://doi.org/10.1136/jmedgenet-2015-103672
- Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., Karapetyan, K., Katz, K., Liu, C., Maddipatla, Z., Malheiro, A., McDaniel, K., Ovetsky, M., Riley, G., Zhou, G., … Maglott, D. R. (2018). ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Research, 46(D1), D1062–D1067. https://doi.org/10.1093/nar/gkx1153
- Manrai, A. K., Funke, B. H., Rehm, H. L., Olesen, M. S., Maron, B. A., Szolovits, P., Margulies, D. M., Loscalzo, J., & Kohane, I. S. (2016). Genetic misdiagnoses and the potential for health disparities. New England Journal of Medicine, 375(7), 655–665. https://doi.org/10.1056/NEJMsa1507092
- May, T. (1994). The concept of autonomy. American Philosophical Quarterly, 31, 133–144.
- May, T. (2009). Bioethics in a liberal society. Johns Hopkins University Press.
- May, T. (2018). Sociogenetic risks - Ancestry DNA testing, third-party identity, and protection of privacy. The New England Journal of Medicine, 379(5), 410–412. https://doi.org/10.1056/NEJMp1805870
- May, T. (2019). The value of genetic testing for family health history of adopted persons. Nature Reviews Genetics, 20(2), 65–66. https://doi.org/10.1038/s41576-018-0080-4
- May, T., and Evans, J., 2020. “Addressing Perceived Economic Obstacles to the Genetic Testing as a Way to Mitigate Disparities in Family Health History for Adoptees,” Health Economics, Policy and Law 15(2), 277–287.
- May, T., & Grotevant, H. (2018). Autonomy, well-being, and the value of genetic testing for adopted persons. HEC Forum, 30(3), 283–295. https://doi.org/10.1007/s10730-017-9345-0
- May, T., Lee, R. M., & Evans, J. P. (2018). Healthcare challenges faced by adopted persons lacking family health history information. Narrative Inquiry in Bioethics, 8(2), 103–106. https://doi.org/10.1353/nib.2018.0036
- May, T., Strong, K. A., Khoury, M. J., & Evans, J. P. (2015). Can targeted genetic testing offer useful health information to adoptees? Genetics in Medicine, 17(7), 533–535. https://doi.org/10.1038/gim.2015.58
- May, T., Strong, K. A., Zusevics, K. L., Jeruzal, J., Farrell, M. H., LaPean Kirschner, A., Derse, A. R., Evans, J. P., & Grotevant, H. D. (2016). Does lack of “genetic-relative family health history” represent a potentially avoidable health disparity for adoptees? The American Journal of Bioethics: AJOB, 16(12), 33–38. https://doi.org/10.1080/15265161.2016.1240255
- May, T., Zusevics, K. L., Derse, A., Strong, K. A., Jeruzal, J., La Pean Kirschner, A., Farrell, M. H., & Spellecy, R. (2014). The limits of traditional approaches to informed consent for genomic medicine. HEC Forum, 26(3), 185–202. https://doi.org/10.1007/s10730-014-9247-3
- McCauley, M. P., Marcus, R. K., Strong, K. A., Visotcky, A. M., Shimoyama, M. E., & Derse, A. R. (2017). Genetics and genomics in clinical practice: The views of Wisconsin physicians. WMJ: Official Publication of the State Medical Society of Wisconsin, 116(2), 69–74.
- Nelson, S. C., & Fullerton, S. M. (2018). “Bridge to the literature”? Third-party genetic interpretation tools and the views of tool developers. Journal of Genetic Counseling, 27(4), 770–781. https://doi.org/10.1007/s10897-018-0217-9
- Parfit, D. (1984). Reasons and persons. Oxford University Press.
- Popejoy, A. B., & Fullerton, S. M. (2016). Genomics is failing on diversity. Nature, 538(7624), 161–164. https://doi.org/10.1038/538161a
- Raz, J. (1986). The morality of freedom. Oxford University Press.
- Servick, K. (2013, November 25). Frustrated FDA issues warning to 23andMe. Science News. https://www.sciencemag.org/news/2013/11/frustrated-us-fda-issues-warning-23andme
- Strong, K. A., May, T., McCauley, M., Pean Kirschner, A. L., Jeruzal, J., Wilson, S. L., Zusevics, K. L., & Knight, C. (2017). Adult adoptees’ attitudes regarding the potential use of genetic information to fill the gap in their family health history. Adoption & Fostering, 41(2), 159–169. https://doi.org/10.1177/0308575917704553
- Tandy-Connor, S., Guiltinan, J., Krempely, K., LaDuca, H., Reineke, P., Gutierrez, S., Gray, P., & Tippin Davis, B. (2018). False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care. Genetics in Medicine, 20(12), 1515–1521. https://doi.org/10.1038/gim.2018.38
- U.S. Food and Drug Administration (FDA). (2013, November 22). Warning letter to 23andMe. https://wayback.archive-it.org/7993/20190423040825/https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm376296.htm
- Welch, H. G., Burke, W. (2015, April 27). Op-ed: Why whole-genome testing hurts more than it helps. Los Angeles Times. https://www.latimes.com/opinion/op-ed/la-oe-welch-problems-predictive-medicine-20150428-story.html
- Zettler, P. J., Sherkow, J. S., & Greely, H. T. (2014). 23andMe, the Food and Drug Administration, and the future of genetic testing. JAMA Internal Medicine, 174(4), 493–494. https://doi.org/10.1001/jamainternmed.2013.14706